Search

Your search keyword '"Toprak, Umut H"' showing total 163 results

Search Constraints

Start Over You searched for: Author "Toprak, Umut H" Remove constraint Author: "Toprak, Umut H"
163 results on '"Toprak, Umut H"'

Search Results

1. Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

3. The genomic and transcriptional landscape of primary central nervous system lymphoma

4. Altered enhancer-promoter interaction leads to MNX1expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

5. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas

7. Super enhancers define regulatory subtypes and cell identity in neuroblastoma

8. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

9. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome

10. Altered enhancer-promoter interaction leads toMNX1expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

11. S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q

12. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

13. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone

14. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

15. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

16. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

17. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

18. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

19. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer

20. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

21. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas

22. Combined burden and functional impact tests for cancer driver discovery using DriverPower

23. Integrative pathway enrichment analysis of multivariate omics data

24. Pathway and network analysis of more than 2500 whole cancer genomes

25. Divergent mutational processes distinguish hypoxic and normoxic tumours

26. Genomic footprints of activated telomere maintenance mechanisms in cancer

27. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature

28. Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia

29. Comprehensive genomic characterization of refractory multiple myeloma reveals a complex mutational and structural landscape associated with drug resistance [Abstract]

30. T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

31. Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia

32. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas

33. T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

34. Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

35. Loss of p16INK4a in neuroblastoma cells induces shift to an immature state with mesenchymal characteristics and increases sensitivity to EGFR inhibitors

36. FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome

38. Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma

39. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma

40. Pan-cancer analysis of whole genomes

41. Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia

42. Accurate and efficient detection of gene fusions from RNA sequencing data

43. Super enhancers define regulatory subtypes and cell identity in neuroblastoma

44. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma

45. Globally altered epigenetic landscape and lagging osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone

46. Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia

47. IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

48. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

49. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

50. IG‐MYC ‐positive leukemia and lymphoma with precursor B‐cell phenotype are genetically and epigenetically distinct from Burkitt lymphomas

Catalog

Books, media, physical & digital resources